Anti-trapping scaffold protein: significance in cancer cell innate immune signaling and opportunities for immunotherapy
Dawit Kidane · 2026
Read Anti-trapping scaffold protein: significance in cancer cell innate immune signaling and opportunities for immunotherapy by Dawit Kidane (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623731.txt.
Description
Dawit Kidane reviews the scaffold protein XRCC1 and its links to cancer immune signaling in this 2026 Europe PMC paper. XRCC1 gathers DNA repair proteins into a working hub and also acts as an anti-trapping protein, releasing them on time to avoid toxicity. It mainly serves single-strand break repair.
Tumors often show low XRCC1 levels, and its loss slows repair, raises mutations and sensitizes cells to radiation and chemotherapy. Recent work shows that combining XRCC1 deficiency with blocking the ATM protein causes mitotic failure and cytosolic DNA buildup, which switches on innate immune signaling in cancer cells. PD-L1 also rose, which may help tumors resist immunity, a tension the review weighs for immunotherapy.
Catalog record
| CREATOR | Dawit Kidane |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |